September 28, 2012
Dr. Linda Vahdat, Director of the Breast Cancer Research Program and Chief of the Solid Tumor Service, Division of Hematology & Medical Oncology, was featured in a MSNBC report on Halaven, a new drug for treating metastatic breast cancer. Halaven is derived from the sea sponge.